Katherine Boothe is an Associate Professor in McMaster’s Political Science department and a member of CHEPA. She holds a PhD and an MA from the University of British Columbia and a BA (Hons.) from the University of Alberta. Her research focuses on comparative public policy in advanced industrial democracies, with a focus on health policy, particularly the development and reform of public pharmaceutical insurance programs.
- Canadian and comparative politics
- public policy in advanced industrial democracies
- health and social policy
Boothe K. Pharmaceutical policy reform in Canada: lessons from history. Health Economics, Policy and Law. 2018. doi:10.1017/S1744133117000408
Morgan S, Boothe K. 2016. Universal prescription drug coverage in Canada: long-promised yet undelivered. Joint Issue of Healthcare Management Forum (Canada) and Health Services Management Research (Europe). 2016. 29(6):247-254.
Boothe K. Evaluating the cost-effectiveness of pharmaceuticals in Canada. Health Reform Observer – Observatoire des Réformes de Santé. 2016. 14(1): 1-20.
Boothe K. Ideas and the pace of change: national pharmaceutical insurance in Canada, Australia, and the United Kingdom. Toronto: University of Toronto Press. 2015.
Boothe K. Ideas and the limits on program expansion: the failure of nation-wide pharmacare in Canada, 1944-2002. Canadian Journal of Political Science. 2013. 46(2): 419-453.
Boothe K. How the pace of change affects the scope of reform: pharmaceutical insurance in Canada, Australia and the UK. Journal of Health Politics, Policy and Law. 2012. 37(5): 779-814.
Morgan S, Boothe K. Prescription drug subsidies in Australia and New Zealand. Australian Prescriber. 2010. 33: 2-4. (peer-reviewed commentary).
Boothe K, Harrison K. The influence of institutions on issues definition: children’s environmental health policy in the United States and Canada. Journal of Comparative Policy Analysis.2009.11(3): 287-307.
Morgan S, Kennedy J, Boothe K, McMahon M, Watson D, Roughead E. Toward an understanding of high performance pharmaceutical policy systems: A “triple-A” framework and example analysis. The Open Health Services and Policy Journal. 2009. 2:1-9.
- comparative public policy
- health policy